CyTuVax cytuvax.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

CyTuVax has developed an intelligent vaccination platform technology for the treatment of cancer. The vaccination technology consists of a powerful adjuvant composed of depot-bound cytokines acting as immune response modifiers. These depot-bound cytokines in precisely defined dose windows are the crucial innovation: they do not merely act as an adjuvant, but also instruct the tissue at the injection site to form a highly organized and active immunological nodule: the inoculum. Within this inocul...Show all

CyTuVax has developed an intelligent vaccination platform technology for the treatment of cancer. The vaccination technology consists of a powerful adjuvant composed of depot-bound cytokines acting as immune response modifiers. These depot-bound cyto...Show all

Company (Alive / Active)

Phone:

Fax:




Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CyTuVax $0M Oct 25, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CyTuVax Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Composition comprising cytokine macro-aggregates Nov 01, 2013 Application